Professional Documents
Culture Documents
Research Article
Introduction
352
353
354
Figure 2 The role of microdomains in IL-2R signalling. The number of high affinity IL-2Rs formed influence the strength of IL-2 Janus
kinase 3 (Jak3)-dependent signal transduction leading to cellular proliferation. If the consequent reduction in the number of intermediate
affinity IL-2Rs falls below a threshold there will be insufficient Jak3-independent antiapoptotic signal transduction. Over-expression of
CD25 may lead to a critical lack of intermediate affinity receptors exposing the cell to possible activation-induced cell death (AICD).
Sequestering of CD25 by microdomain immobilization will prevent the formation of high affinity IL-2R and a subsequent reduction in
Jak3-dependent cell proliferation.
, CD 122; , plasma membrane; , CD 25; , microdomain.
355
Figure 3 Interleukin-15 signalling occurs outside of microdomains. The ability of IL-15R to bind tumour necrosis factor receptorassociated factor 2 (TRAF2) coupled with activation of Janus kinase 3 (Jak3)-independent antiapoptotic signalling protects against
activation induced cell death (AICD). The orientation of the receptor complex and its stability allows Jak1/Jak3 activation to promote
cell proliferation. , IL-15R; , CD122, , IL-2Rc.
Conclusion
Although the receptors for IL-2 and IL-15 share CD122 and
the C subunit they have different cellular effects and contrasting roles within the body. In this paper we have put forward a
mechanism to explain how the private alpha subunits of the
receptors mediate these differences. The intermediate affinity
356
References
1 Giri JG, Ahdie M, Shanebeck K et al. Utilization of the beta and
gamma chains of the IL-2 receptor by the novel cytokine IL-15.
EMBO J. 1994; 13: 282230.
2 Nakamura Y, Russell SM, Mess SA et al. Heterodimerization of
the IL-2 receptor beta and gamma chain cytoplasmic domains is
required for signalling. Nature 1994; 369: 3303.
3 Johnston JA, Bacon CM, Finbloom DS et al. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by
interleukins 2 and 15. PNAS 1995; 92: 87059.
4 Lorenz HM, Hieronymus T, Grunke M, Manger B, Kalden JR.
Differential role for IL-2 and IL-15 in the inhibition of apoptosis
in short-term activated human lymphocytes. Scand. J. Immunol.
1997; 45: 6609.
5 Sharfe N, Harijit KD, Shahar M, Roifman CM. Human immune
disorder arising from mutation of the chain of the interleukin-2
receptor. PNAS 1997; 94: 316871.
6 Roifman CM. Human IL-2 receptor alpha chain deficiency.
Pediatr. Res. 2000; 48: 611.
7 Lodolce JP, Boone DL, Chai S et al. IL-15 receptor maintains
lymphoid homeostasis by supporting lymphocyte homing and
proliferation. Immunity 1998; 9: 66976.
8 Gonzalez-Garcia A, Merida I, Martinez AC, Carrera AC. Intermediate affinity interleukin-2 receptor mediates survival via a
phosphatidylinositol 3-kinase-dependent pathway. JBC 1997;
272: 10 2206.
9 Tsujino S, Miyazaki T, Kawahara A, Maeda M, Taniguchi T,
Fujii H. Critical role of the membrane-proximal, proline-rich
motif of the interleukin-2 receptor gamma c chain in the Jak3independent signal transduction. Genes Cells 1999; 4: 36373.
10 Ellery JM, Kempshall SJ, Nicholls PJ. Activation of the interleukin 2 receptor: a possible role for tyrosine phosphatases. Cellular Signalling 2000; 12: 36773.
11 Tsujino S, Di Santo JP, Takaoka A et al. Differential requirement of the cytoplasmic subregions of C chain in T cell development and function. PNAS 2000; 97: 10 51419.
12 Viola A. The amplification of TCR signaling by dynamic membrane microdomains. Trends Immunol. 2001; 22: 3227.
13 Miceli MC, Moran M, Chung CD, Patel VP, Low T, Zinnanti W.
Co-stimulation and counter-stimulation; lipid raft clustering controls TCR signaling and functional outcomes. Semin. Immunol.
2001; 13: 11528.
14 Janes PW, Ley SC, Magee AI, Kabouridis PS. The role of lipid
rafts in T cell antigen receptor (TCR) signalling. Semin. Immunol. 2000; 12: 2334.
15 Szamel M, Appel A, Schwinzer R, Resch K. Different protein
kinase C isoenzymes regulate IL-2 receptor expression or IL-2
synthesis in human lymphocytes stimulated via the TCR. J.
Immunol. 1998; 160: 220714.
16 Chae DW, Nosaka Y, Strom TB, Maslinski W. Distribution of
IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor
expression. J. Immunol. 1996; 157: 281319.
17 Vereb G, Matk J, Vmosi G et al. Cholesterol-dependent clustering of IL-2R and its colocalization with HLA and CD48 on
T lymphoma cells suggest their functional association with lipid
rafts. PNAS 2000; 97: 601318.
18 Field KA, Holowka D, Braid B. Structural aspects of the association of FcRI with detergent-resistant membranes. JBC 1999;
274: 17538.
19 Landgraf BE, Goldstein B, Williams DP et al. Recombinant
interleukin-2 analogs. Dynamic probes for receptor structure.
JBC 1992; 267: 18 51119.
20 Myszka DG, Arulanantham PR, Sana T, Wu Z, Morton TA,
Ciardelli TL. Kinetic analysis of ligand binding to interleukin-2
receptor complexes created on an optical biosensor surface.
Protein Sci. 1996; 5: 246878.
21 Goldsmith MA, Amaral MC, Greene WC. Ligand binding by the
IL-2 receptor is modulated by intracellular determinants of the
IL-2 receptor beta chain. J. Immunol. 1995; 154: 203340.
22 Damjanovich S, Bene L, Matko J et al. Pre-assembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225, K6 T cells
and their modulation by IL-2, IL-7, and IL-15: A fluorescence
resonance energy transfer study. PNAS 1997; 94: 131349.
23 Hemar A, Subtil A, Lieb M et al. Endocytosis of interleukin 2
receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains. J.
Cell. Biol. 1995; 129: 5564.
24 Rocca A, Lamaze C, Subtil A et al. Involvement of the ubiquitin/
proteasome system in sorting of the interleukin 2 receptor
chain to late endocytic compartments. Mol. Biol. Cell 2001; 12:
1293301.
25 Syed RS, Reid SW, Li C et al. Efficiency of signalling through
cytokine receptors depends critically on receptor orientation.
Nature 1998; 395: 51116.
26 Akaishi H, Takeda K, Kaisho T et al. Defective IL-2-mediated
IL-2 receptor alpha chain expression in Stat3-deficient lymphocytes. Int. Immunol. 1998; 10: 174751.
27 Nakajima H, Liu XW, Wynshaw-Boris A et al. An indirect effect
of Stat5a in IL-2-induced proliferation: a critical role for Stat5a
in IL-2-mediated IL-2 receptor alpha chain induction. Immunity
1997; 7: 691701.
28 Marmor MD, Bachmann MF, Ohashi PS, Malek TR, Julius M.
Immobilization of glycosylphosphatidylinositol-anchored proteins inhibits T cell growth but not function. Int. Immunol. 1999;
11: 138193.
29 Matk J, Bodnr A, Vereb G et al. GPI-microdomains (membrane rafts) and signalling of the multi-chain interleukin-2
receptor in human lymphoma/leukaemia T cell lines. Eur. J. Biochem. 2002; 269: 1199208.
30 Marmor MD, Julius M. Role for lipid rafts in regulating
interleukin-2 receptor signalling. Blood 2001; 98: 148997.
31 Zhou Y-J, Magnuson KS, Cheng TP et al. Hierarchy of protein
tyrosine kinases in interleukin-2 (IL-2) signalling: Activation of
Syk depends on Jak3; however, neither Syk nor Lck is required
for IL-2-mediated STAT activation. Mol. Cell Biol. 2000; 20:
437180.
32 Dai Z, Arakelov A, Wagener M, Konieczny BT, Lakkis FG. The
role of the common cytokine receptor -chain in regulating IL-2dependent, activation-induced CD8= T cell death. J. Immunol.
1999; 163: 31317.
33 Marks-Konczalik J, Dubois S, Losi JM et al. IL-2-induced
activation-induced cell death is inhibited in IL-15 transgenic
mice. PNAS 2000; 97: 11 44550.
34 Duprez V, Cornet V, Dautry-Varsat A. Down-regulation of high
affinity interleukin 2 receptors in a human tumor T cell line. JBC
1988; 263: 12 8605.
35 Saijo K, Park SY, Ishida Y, Arase H, Saito T. Crucial role of
Jak3 in negative selection of self-reactive T cells. J. Exp. Med.
1997; 185: 3516.
357